Alimera Sciences

ALIM · NASDAQ

Price unavailable right now.

No price history for this range.

About ALIM

Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is headquartered in Alpharetta, Georgia and currently employs 159 full-time employees. The firm is focused on helping patients, physicians and partners concerned with retinal health and maintaining better vision longer.

Employees
157
Headquarters
Alpharetta, Georgia
Listed
Apr 22, 2010
Sector
Health Care
Industry
Pharmaceuticals

ALIM key statistics

This section is temporarily unavailable. Refresh to try again.

ALIM earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 8.8% on average.

  1. Q3 FY22: reported -$0.75 per share against an estimate of -$0.4114
  2. Q4 FY22: reported -$0.54 per share against an estimate of -$0.3417
  3. Q1 FY23: reported -$0.71 per share against an estimate of -$0.3264
  4. Q2 FY23: reported -$1.32 per share against an estimate of $0.0153
  5. Q3 FY23: reported -$0.06 per share against an estimate of -$0.0658
  6. Q4 FY23: reported -$0.07 per share against an estimate of $0.00
  7. Q1 FY24: reported -$0.12 per share against an estimate of -$0.0578
  8. Q2 FY24: reported -$0.06 per share against an estimate of -$0.0374

ALIM news

  • Press releaseGlobe Newswire

    ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

  • Press releaseBusiness Wire

    ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

  • Avi Kapoor

    Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook

  • Avi Kapoor

    Dow Dips Around 1%; US Small Business Optimism Falls In August

  • Press releaseBusiness Wire

    Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of Shareholders

  • Press releaseBusiness Wire

    ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, CALT on Behalf of Shareholders

Similar companies

Companies in the same industry as Alimera Sciences

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.